[Form 3] X4 Pharmaceuticals, Inc. Initial Statement of Beneficial Ownership
Craig Adam R, serving as Executive Chairman and a Director of X4 Pharmaceuticals, Inc. (XFOR), filed an initial Form 3 dated 08/12/2025 reporting that he does not beneficially own any securities of the issuer. The filing includes an Exhibit 24 Power of Attorney and is signed on behalf of the reporting person by an attorney-in-fact on 08/14/2025.
Craig Adam R, ricoprendo il ruolo di Presidente esecutivo e un Membro del Consiglio di Amministrazione di X4 Pharmaceuticals, Inc. (XFOR), ha presentato un primo Form 3 datato 08/12/2025 riportando che non detiene in modo beneficiario alcuna partecipazione nell'emittente. La presentazione include un Exhibit 24 Power of Attorney ed è firmata per conto della persona che riporta da un procuratore incaricato (attorney-in-fact) in data 08/14/2025.
Craig Adam R, desempeñando como Presidente ejecutivo y Director de X4 Pharmaceuticals, Inc. (XFOR), presentó un Form 3 inicial fechado el 08/12/2025 informando que no posee de forma beneficiosa ninguna seguridad del emisor. La presentación incluye un Exhibit 24 Power of Attorney y está firmada en nombre de la persona reportante por un apoderado (attorney-in-fact) en 08/14/2025.
Craig Adam R은 Executive Chairman 및 Director로서 X4 Pharmaceuticals, Inc. (XFOR)의 임원으로 활동하며, 발행회사 주식을 beneficially own하지 않는다고 보고하는 최초의 Form 3를 08/12/2025자로 제출했습니다. 이 제출에는 Exhibit 24 Power of Attorney가 포함되어 있으며, 피보고자(보고하는 사람)를 대신하여 대리인에 의해 08/14/2025에 서명되었습니다.
Craig Adam R, exerçant les fonctions de Président-Directeur Général et de Membre du Conseil d'Administration de X4 Pharmaceuticals, Inc. (XFOR), a déposé un premier Form 3 daté du 08/12/2025 indiquant qu'il ne détient pas de titres de l'émetteur à titre bénéficiaire. Le dépôt comprend un Exhibit 24 Power of Attorney et est signé au nom de la personne déclarant par un mandataire en date du 08/14/2025.
Craig Adam R, der als Executive Chairman und Director von X4 Pharmaceuticals, Inc. (XFOR) fungiert, hat eine anfängliche Form 3 mit dem Datum 08/12/2025 eingereicht, in der er angibt, dass er keine wirtschaftlich berechtigte Beteiligung am Emittenten hält. Die Einreichung beinhaltet eine Exhibit 24 Power of Attorney und ist im Namen der meldenden Person von einem Bevollmächtigten am 08/14/2025 unterschrieben.
Craig Adam R، يعمل كـ رئيس تنفيذي ورئيس المجلس ومدير في X4 Pharmaceuticals, Inc. (XFOR)، قدم نموذجاً أولياً Form 3 مؤرخ بـ 08/12/2025 يفيد بأنه لا يملك أي أسهم بقيمة فاعلة للمصدر. يتضمن الملف Exhibit 24 Power of Attorney وموقع نيابة عن الشخص المبلغ عنه من قبل وكيل مفوَّض في 08/14/2025.
Craig Adam R，担任 执行主席以及 X4 Pharmaceuticals, Inc. (XFOR)的 董事，提交了日期为 08/12/2025 的初始 Form 3，报告其并不对发行人持有任何有益证券。该申报包含一个Exhibit 24 Power of Attorney，并由被报告人之代理律师于 08/14/2025 代表其签字。
- None.
- No securities beneficially owned reported by the Executive Chairman as of 08/12/2025
Craig Adam R, ricoprendo il ruolo di Presidente esecutivo e un Membro del Consiglio di Amministrazione di X4 Pharmaceuticals, Inc. (XFOR), ha presentato un primo Form 3 datato 08/12/2025 riportando che non detiene in modo beneficiario alcuna partecipazione nell'emittente. La presentazione include un Exhibit 24 Power of Attorney ed è firmata per conto della persona che riporta da un procuratore incaricato (attorney-in-fact) in data 08/14/2025.
Craig Adam R, desempeñando como Presidente ejecutivo y Director de X4 Pharmaceuticals, Inc. (XFOR), presentó un Form 3 inicial fechado el 08/12/2025 informando que no posee de forma beneficiosa ninguna seguridad del emisor. La presentación incluye un Exhibit 24 Power of Attorney y está firmada en nombre de la persona reportante por un apoderado (attorney-in-fact) en 08/14/2025.
Craig Adam R은 Executive Chairman 및 Director로서 X4 Pharmaceuticals, Inc. (XFOR)의 임원으로 활동하며, 발행회사 주식을 beneficially own하지 않는다고 보고하는 최초의 Form 3를 08/12/2025자로 제출했습니다. 이 제출에는 Exhibit 24 Power of Attorney가 포함되어 있으며, 피보고자(보고하는 사람)를 대신하여 대리인에 의해 08/14/2025에 서명되었습니다.
Craig Adam R, exerçant les fonctions de Président-Directeur Général et de Membre du Conseil d'Administration de X4 Pharmaceuticals, Inc. (XFOR), a déposé un premier Form 3 daté du 08/12/2025 indiquant qu'il ne détient pas de titres de l'émetteur à titre bénéficiaire. Le dépôt comprend un Exhibit 24 Power of Attorney et est signé au nom de la personne déclarant par un mandataire en date du 08/14/2025.
Craig Adam R, der als Executive Chairman und Director von X4 Pharmaceuticals, Inc. (XFOR) fungiert, hat eine anfängliche Form 3 mit dem Datum 08/12/2025 eingereicht, in der er angibt, dass er keine wirtschaftlich berechtigte Beteiligung am Emittenten hält. Die Einreichung beinhaltet eine Exhibit 24 Power of Attorney und ist im Namen der meldenden Person von einem Bevollmächtigten am 08/14/2025 unterschrieben.
FAQ
What did the Form 3 filed for XFOR report?
What is Craig Adam R's role at X4 Pharmaceuticals (XFOR)?
Was the Form 3 signed and are there exhibits?
Does the Form 3 show any derivative or non-derivative holdings?
Was the Form 3 filed individually or jointly?
